EU Getting Left Behind On Drug Review Times
EU Review Times Aren't So Much Lagging As Other Agencies Are Improving
Executive Summary
Drug review times in the EU are not getting slower but other agencies are getting faster. A pharmaceutical industry representative offers some frank advice on how the EU can stay competitive.